The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Compounded "semaglutide" is not FDA approved semaglutide.com Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC